• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

46.6400 USD 0.4800 1.04%

As of 10:15:21 ET on 09/22/2014.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 46.8300 High - Low: 46.9200 - 46.5000 Primary Exchange: NYSE Arca
Volume: 4,162 52-Week Range: 33.0400 - 48.1200 Beta vs DZOTR: 0.9984

ETF Chart for PBE

No chart data available.
  • PBE:US 46.5300
  • 1D
  • 1M
  • 1Y
46.1600
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2014-09-19) 46.1873
Assets (M) (on 2014-09-19) 394.9017
Shares out (M) 8.55
Market Cap (M) 394.67
% Premium -0.06
Average 52-Week % Premium 0.0195
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.60%

Performance for PBE

1-Month +0.20% 1-Year +30.58%
3-Month +5.16% 3-Year +33.77%
Year To Date +25.36% 5-Year +22.22%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 09/19/2014
Name Position Value % of Total
Amgen Inc 144,690 20,836,807 5.276%
Regeneron Pharmaceuticals Inc 57,534 20,650,103 5.229%
Pharmacyclics Inc 162,126 20,025,804 5.071%
Gilead Sciences Inc 187,459 19,863,156 5.030%
Sigma-Aldrich Corp 193,912 19,850,771 5.027%
Illumina Inc 112,438 19,368,570 4.904%
Biogen Idec Inc 58,789 19,355,690 4.901%
Alexion Pharmaceuticals Inc 119,126 19,231,701 4.870%
Medivation Inc 120,536 12,326,011 3.121%
United Therapeutics Corp 93,355 12,147,353 3.076%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil